APRAMEYA ENGINEERING LTD

APRAMEYAMedical Equipment & Supplies
260.75+0.00 (+0.00%)
As on 29 Jan 2026, 10:35 amMarket Closed

Fundamental Score

...

APRAMEYA ENGINEERING LTD Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Excellent

Return on Equity

36.78%
Excellent

Return on Capital Employed

31.12%
Excellent

Operating Profit Margin (5Y)

15.49%
Poor

Dividend Yield

0.00%

Valuation Metrics

Excellent

Price to Earnings

25.77x

Market Capitalization

633.93 (Cr)

Industry P/E

47.87x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

490.75%
Excellent

YoY Quarterly Sales Growth

354.58%
Excellent

Sales Growth (5Y)

61.82%

EPS Growth (5Y)

N/A
Excellent

Profit Growth (5Y)

90.06%

Financial Health

Poor

Debt to Equity

0.53x
Excellent

Interest Coverage

9.16x
Poor

Free Cash Flow (5Y)

-21.06 (Cr)

Ownership Structure

Good

Promoter Holding

73.53%
Poor

FII Holding

0.00%
Poor

DII Holding

0.77%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
73.53%
Promoter Holding
633.93 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of APRAMEYA across key market metrics for learning purposes.

Positive Indicators

11 factors identified

Strong Return on Equity (36.78%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (31.12%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Strong Operating Margins (15.49%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Attractive Valuation (P/E: 25.77 vs Industry: 47.87)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Robust Profit Growth (490.75%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (354.58%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Consistent Growth Track Record (61.82% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Strong Profit Growth Track Record (90.06% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Strong Interest Coverage (9.16x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Balanced Promoter Holding (73.53%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

3 factors identified

Negative Free Cash Flow (₹-21.06 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

Limited Institutional Interest (FII+DII: 0.77%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

Financial Statements

Comprehensive financial data for APRAMEYA ENGINEERING LTD

About APRAMEYA

Company Details

Symbol:APRAMEYA
Industry:Medical Equipment & Supplies
Sector:Medical Equipment & Supplies
Website:N/A

APRAMEYA Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)36.78%
Return on Capital Employed31.12%
Operating Profit Margin (5Y)15.49%
Debt to Equity Ratio0.53
Interest Coverage Ratio9.16

Growth & Valuation

Sales Growth (5Y)61.82%
Profit Growth (5Y)90.06%
EPS Growth (5Y)N/A%
YoY Quarterly Profit Growth490.75%
YoY Quarterly Sales Growth354.58%

Frequently Asked Questions

What is the current price of APRAMEYA ENGINEERING LTD (APRAMEYA)?

As of 29 Jan 2026, 10:35 am IST, APRAMEYA ENGINEERING LTD (APRAMEYA) is currently trading at ₹260.75. The stock has a market capitalization of ₹633.93 (Cr).

Is APRAMEYA share price Overvalued or Undervalued?

APRAMEYA is currently trading at a P/E ratio of 25.77x, compared to the industry average of 47.87x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.

What factors affect the APRAMEYA ENGINEERING LTD share price?

Key factors influencing APRAMEYA's price include its quarterly earnings growth (Sales Growth: 354.58%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is APRAMEYA ENGINEERING LTD a good stock for long-term investment?

APRAMEYA ENGINEERING LTD shows a 5-year Profit Growth of 90.06% and an ROE of 36.78%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.53 before investing.

How does APRAMEYA ENGINEERING LTD compare with its industry peers?

APRAMEYA ENGINEERING LTD competes with major peers in the Medical Equipment & Supplies. Investors should compare APRAMEYA's P/E of 25.77x and ROE of 36.78% against the industry averages to determine its competitive standing.

What is the P/E ratio of APRAMEYA and what does it mean?

APRAMEYA has a P/E ratio of 25.77x compared to the industry average of 47.87x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹26 for every ₹1 of annual earnings.

How is APRAMEYA performing according to Bull Run's analysis?

APRAMEYA has a Bull Run fundamental score of 60.3/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does APRAMEYA belong to?

APRAMEYA operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting APRAMEYA ENGINEERING LTD.

What is Return on Equity (ROE) and why is it important for APRAMEYA?

APRAMEYA has an ROE of 36.78%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently APRAMEYA ENGINEERING LTD generates profits from shareholders' equity.

How is APRAMEYA's debt-to-equity ratio and what does it indicate?

APRAMEYA has a debt-to-equity ratio of 0.53, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.

What is APRAMEYA's dividend yield and is it a good dividend stock?

APRAMEYA offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has APRAMEYA grown over the past 5 years?

APRAMEYA has achieved 5-year growth rates of: Sales Growth 61.82%, Profit Growth 90.06%, and EPS Growth N/A%.

What is the promoter holding in APRAMEYA and why does it matter?

Promoters hold 73.53% of APRAMEYA shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is APRAMEYA's market capitalization category?

APRAMEYA has a market capitalization of ₹634 crores, placing it in the Small-cap category.

How volatile is APRAMEYA stock?

APRAMEYA has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for APRAMEYA?

APRAMEYA has a 52-week high of ₹N/A and low of ₹N/A.

What is APRAMEYA's operating profit margin trend?

APRAMEYA has a 5-year average Operating Profit Margin (OPM) of 15.49%, indicating the company's operational efficiency.

How is APRAMEYA's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 354.58% and YoY Profit Growth of 490.75%.

What is the institutional holding pattern in APRAMEYA?

APRAMEYA has FII holding of 0.00% and DII holding of 0.77%. Significant institutional holding often suggests professional confidence in the stock.